The global Melanoma Drugs market was valued at US$ 2154.4 million in 2023 and is anticipated to reach US$ 4803.4 million by 2030, witnessing a CAGR of 12.0% during the forecast period 2024-2030.

Melanoma Drugs Market

Melanoma drugs are medications used to treat melanoma, a type of skin cancer. They include targeted therapies, immunotherapies, and chemotherapy drugs.

The market for melanoma drugs is driven by the rising incidence of melanoma and the demand for effective and personalized cancer treatments. The market's growth is also influenced by ongoing research in melanoma therapeutics, leading to the development of novel drugs and combination therapies.

This report aims to provide a comprehensive presentation of the global market for Melanoma Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melanoma Drugs.

Report Scope

The Melanoma Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Melanoma Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Melanoma Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Melanoma Drugs Market Report

Report Metric	Details
Report Name	Melanoma Drugs Market
Accounted market size in 2023	US$ 2154.4 million
Forecasted market size in 2030	US$ 4803.4 million
CAGR	12.0%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Chemotherapy Immunotherapy Targeted Therapy
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Amgen, Bristol-Myers Squibb, Roche, Genentech, Janssen Biotech, Novartis, Pfizer, Sanofi, Takeda Pharma, Teva Pharma, Merck Group, Shanghai Junshi Biosciences Co.,Ltd, Innovent Biologics, Jiangsu Hengrui Medicine Co.,Ltd., BeiGene, Ltd., Grand Pharmaceutical (China) Co., Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Melanoma Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Melanoma Drugs Market growing?

Ans: The Melanoma Drugs Market witnessing a CAGR of 12.0% during the forecast period 2024-2030.

What is the Melanoma Drugs Market size in 2030?

Ans: The Melanoma Drugs Market size in 2030 will be US$ 4803.4 million.

Who are the main players in the Melanoma Drugs Market report?

Ans: The main players in the Melanoma Drugs Market are Amgen, Bristol-Myers Squibb, Roche, Genentech, Janssen Biotech, Novartis, Pfizer, Sanofi, Takeda Pharma, Teva Pharma, Merck Group, Shanghai Junshi Biosciences Co.,Ltd, Innovent Biologics, Jiangsu Hengrui Medicine Co.,Ltd., BeiGene, Ltd., Grand Pharmaceutical (China) Co., Ltd

What are the Application segmentation covered in the Melanoma Drugs Market report?

Ans: The Applications covered in the Melanoma Drugs Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Melanoma Drugs Market report?

Ans: The Types covered in the Melanoma Drugs Market report are Chemotherapy, Immunotherapy, Targeted Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Melanoma Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Chemotherapy

1.2.3 Immunotherapy

1.2.4 Targeted Therapy

1.3 Market by Application

1.3.1 Global Melanoma Drugs Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Melanoma Drugs Market Perspective (2019-2030)

2.2 Melanoma Drugs Growth Trends by Region

2.2.1 Global Melanoma Drugs Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Melanoma Drugs Historic Market Size by Region (2019-2024)

2.2.3 Melanoma Drugs Forecasted Market Size by Region (2025-2030)

2.3 Melanoma Drugs Market Dynamics

2.3.1 Melanoma Drugs Industry Trends

2.3.2 Melanoma Drugs Market Drivers

2.3.3 Melanoma Drugs Market Challenges

2.3.4 Melanoma Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Melanoma Drugs Players by Revenue

3.1.1 Global Top Melanoma Drugs Players by Revenue (2019-2024)

3.1.2 Global Melanoma Drugs Revenue Market Share by Players (2019-2024)

3.2 Global Melanoma Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Melanoma Drugs Revenue

3.4 Global Melanoma Drugs Market Concentration Ratio

3.4.1 Global Melanoma Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Melanoma Drugs Revenue in 2023

3.5 Melanoma Drugs Key Players Head office and Area Served

3.6 Key Players Melanoma Drugs Product Solution and Service

3.7 Date of Enter into Melanoma Drugs Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Melanoma Drugs Breakdown Data by Type

4.1 Global Melanoma Drugs Historic Market Size by Type (2019-2024)

4.2 Global Melanoma Drugs Forecasted Market Size by Type (2025-2030)

5 Melanoma Drugs Breakdown Data by Application

5.1 Global Melanoma Drugs Historic Market Size by Application (2019-2024)

5.2 Global Melanoma Drugs Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Melanoma Drugs Market Size (2019-2030)

6.2 North America Melanoma Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Melanoma Drugs Market Size by Country (2019-2024)

6.4 North America Melanoma Drugs Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Melanoma Drugs Market Size (2019-2030)

7.2 Europe Melanoma Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Melanoma Drugs Market Size by Country (2019-2024)

7.4 Europe Melanoma Drugs Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Melanoma Drugs Market Size (2019-2030)

8.2 Asia-Pacific Melanoma Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Melanoma Drugs Market Size by Region (2019-2024)

8.4 Asia-Pacific Melanoma Drugs Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Melanoma Drugs Market Size (2019-2030)

9.2 Latin America Melanoma Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Melanoma Drugs Market Size by Country (2019-2024)

9.4 Latin America Melanoma Drugs Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Melanoma Drugs Market Size (2019-2030)

10.2 Middle East & Africa Melanoma Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Melanoma Drugs Market Size by Country (2019-2024)

10.4 Middle East & Africa Melanoma Drugs Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Amgen

11.1.1 Amgen Company Detail

11.1.2 Amgen Business Overview

11.1.3 Amgen Melanoma Drugs Introduction

11.1.4 Amgen Revenue in Melanoma Drugs Business (2019-2024)

11.1.5 Amgen Recent Development

11.2 Bristol-Myers Squibb

11.2.1 Bristol-Myers Squibb Company Detail

11.2.2 Bristol-Myers Squibb Business Overview

11.2.3 Bristol-Myers Squibb Melanoma Drugs Introduction

11.2.4 Bristol-Myers Squibb Revenue in Melanoma Drugs Business (2019-2024)

11.2.5 Bristol-Myers Squibb Recent Development

11.3 Roche

11.3.1 Roche Company Detail

11.3.2 Roche Business Overview

11.3.3 Roche Melanoma Drugs Introduction

11.3.4 Roche Revenue in Melanoma Drugs Business (2019-2024)

11.3.5 Roche Recent Development

11.4 Genentech

11.4.1 Genentech Company Detail

11.4.2 Genentech Business Overview

11.4.3 Genentech Melanoma Drugs Introduction

11.4.4 Genentech Revenue in Melanoma Drugs Business (2019-2024)

11.4.5 Genentech Recent Development

11.5 Janssen Biotech

11.5.1 Janssen Biotech Company Detail

11.5.2 Janssen Biotech Business Overview

11.5.3 Janssen Biotech Melanoma Drugs Introduction

11.5.4 Janssen Biotech Revenue in Melanoma Drugs Business (2019-2024)

11.5.5 Janssen Biotech Recent Development

11.6 Novartis

11.6.1 Novartis Company Detail

11.6.2 Novartis Business Overview

11.6.3 Novartis Melanoma Drugs Introduction

11.6.4 Novartis Revenue in Melanoma Drugs Business (2019-2024)

11.6.5 Novartis Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Detail

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Melanoma Drugs Introduction

11.7.4 Pfizer Revenue in Melanoma Drugs Business (2019-2024)

11.7.5 Pfizer Recent Development

11.8 Sanofi

11.8.1 Sanofi Company Detail

11.8.2 Sanofi Business Overview

11.8.3 Sanofi Melanoma Drugs Introduction

11.8.4 Sanofi Revenue in Melanoma Drugs Business (2019-2024)

11.8.5 Sanofi Recent Development

11.9 Takeda Pharma

11.9.1 Takeda Pharma Company Detail

11.9.2 Takeda Pharma Business Overview

11.9.3 Takeda Pharma Melanoma Drugs Introduction

11.9.4 Takeda Pharma Revenue in Melanoma Drugs Business (2019-2024)

11.9.5 Takeda Pharma Recent Development

11.10 Teva Pharma

11.10.1 Teva Pharma Company Detail

11.10.2 Teva Pharma Business Overview

11.10.3 Teva Pharma Melanoma Drugs Introduction

11.10.4 Teva Pharma Revenue in Melanoma Drugs Business (2019-2024)

11.10.5 Teva Pharma Recent Development

11.11 Merck Group

11.11.1 Merck Group Company Detail

11.11.2 Merck Group Business Overview

11.11.3 Merck Group Melanoma Drugs Introduction

11.11.4 Merck Group Revenue in Melanoma Drugs Business (2019-2024)

11.11.5 Merck Group Recent Development

11.12 Shanghai Junshi Biosciences Co.,Ltd

11.12.1 Shanghai Junshi Biosciences Co.,Ltd Company Detail

11.12.2 Shanghai Junshi Biosciences Co.,Ltd Business Overview

11.12.3 Shanghai Junshi Biosciences Co.,Ltd Melanoma Drugs Introduction

11.12.4 Shanghai Junshi Biosciences Co.,Ltd Revenue in Melanoma Drugs Business (2019-2024)

11.12.5 Shanghai Junshi Biosciences Co.,Ltd Recent Development

11.13 Innovent Biologics

11.13.1 Innovent Biologics Company Detail

11.13.2 Innovent Biologics Business Overview

11.13.3 Innovent Biologics Melanoma Drugs Introduction

11.13.4 Innovent Biologics Revenue in Melanoma Drugs Business (2019-2024)

11.13.5 Innovent Biologics Recent Development

11.14 Jiangsu Hengrui Medicine Co.,Ltd.

11.14.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Detail

11.14.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview

11.14.3 Jiangsu Hengrui Medicine Co.,Ltd. Melanoma Drugs Introduction

11.14.4 Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Melanoma Drugs Business (2019-2024)

11.14.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Development

11.15 BeiGene, Ltd.

11.15.1 BeiGene, Ltd. Company Detail

11.15.2 BeiGene, Ltd. Business Overview

11.15.3 BeiGene, Ltd. Melanoma Drugs Introduction

11.15.4 BeiGene, Ltd. Revenue in Melanoma Drugs Business (2019-2024)

11.15.5 BeiGene, Ltd. Recent Development

11.16 Grand Pharmaceutical (China) Co., Ltd

11.16.1 Grand Pharmaceutical (China) Co., Ltd Company Detail

11.16.2 Grand Pharmaceutical (China) Co., Ltd Business Overview

11.16.3 Grand Pharmaceutical (China) Co., Ltd Melanoma Drugs Introduction

11.16.4 Grand Pharmaceutical (China) Co., Ltd Revenue in Melanoma Drugs Business (2019-2024)

11.16.5 Grand Pharmaceutical (China) Co., Ltd Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Shanghai Junshi Biosciences Co.,Ltd

Innovent Biologics

Jiangsu Hengrui Medicine Co Ltd

BeiGene Ltd

Grand Pharmaceutical (China) Co., Ltd

List of Tables

Table 1. Global Melanoma Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Chemotherapy

Table 3. Key Players of Immunotherapy

Table 4. Key Players of Targeted Therapy

Table 5. Global Melanoma Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Melanoma Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Melanoma Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Melanoma Drugs Market Share by Region (2019-2024)

Table 9. Global Melanoma Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Melanoma Drugs Market Share by Region (2025-2030)

Table 11. Melanoma Drugs Market Trends

Table 12. Melanoma Drugs Market Drivers

Table 13. Melanoma Drugs Market Challenges

Table 14. Melanoma Drugs Market Restraints

Table 15. Global Melanoma Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Melanoma Drugs Market Share by Players (2019-2024)

Table 17. Global Top Melanoma Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Drugs as of 2023)

Table 18. Ranking of Global Top Melanoma Drugs Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Melanoma Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Melanoma Drugs Product Solution and Service

Table 22. Date of Enter into Melanoma Drugs Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Melanoma Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Melanoma Drugs Revenue Market Share by Type (2019-2024)

Table 26. Global Melanoma Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Melanoma Drugs Revenue Market Share by Type (2025-2030)

Table 28. Global Melanoma Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Melanoma Drugs Revenue Market Share by Application (2019-2024)

Table 30. Global Melanoma Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Melanoma Drugs Revenue Market Share by Application (2025-2030)

Table 32. North America Melanoma Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Melanoma Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Melanoma Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Melanoma Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Melanoma Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Melanoma Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Melanoma Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Melanoma Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Melanoma Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Melanoma Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Melanoma Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Melanoma Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Melanoma Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Melanoma Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Melanoma Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 47. Amgen Company Detail

Table 48. Amgen Business Overview

Table 49. Amgen Melanoma Drugs Product

Table 50. Amgen Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 51. Amgen Recent Development

Table 52. Bristol-Myers Squibb Company Detail

Table 53. Bristol-Myers Squibb Business Overview

Table 54. Bristol-Myers Squibb Melanoma Drugs Product

Table 55. Bristol-Myers Squibb Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 56. Bristol-Myers Squibb Recent Development

Table 57. Roche Company Detail

Table 58. Roche Business Overview

Table 59. Roche Melanoma Drugs Product

Table 60. Roche Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 61. Roche Recent Development

Table 62. Genentech Company Detail

Table 63. Genentech Business Overview

Table 64. Genentech Melanoma Drugs Product

Table 65. Genentech Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 66. Genentech Recent Development

Table 67. Janssen Biotech Company Detail

Table 68. Janssen Biotech Business Overview

Table 69. Janssen Biotech Melanoma Drugs Product

Table 70. Janssen Biotech Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 71. Janssen Biotech Recent Development

Table 72. Novartis Company Detail

Table 73. Novartis Business Overview

Table 74. Novartis Melanoma Drugs Product

Table 75. Novartis Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 76. Novartis Recent Development

Table 77. Pfizer Company Detail

Table 78. Pfizer Business Overview

Table 79. Pfizer Melanoma Drugs Product

Table 80. Pfizer Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 81. Pfizer Recent Development

Table 82. Sanofi Company Detail

Table 83. Sanofi Business Overview

Table 84. Sanofi Melanoma Drugs Product

Table 85. Sanofi Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 86. Sanofi Recent Development

Table 87. Takeda Pharma Company Detail

Table 88. Takeda Pharma Business Overview

Table 89. Takeda Pharma Melanoma Drugs Product

Table 90. Takeda Pharma Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 91. Takeda Pharma Recent Development

Table 92. Teva Pharma Company Detail

Table 93. Teva Pharma Business Overview

Table 94. Teva Pharma Melanoma Drugs Product

Table 95. Teva Pharma Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 96. Teva Pharma Recent Development

Table 97. Merck Group Company Detail

Table 98. Merck Group Business Overview

Table 99. Merck Group Melanoma Drugs Product

Table 100. Merck Group Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 101. Merck Group Recent Development

Table 102. Shanghai Junshi Biosciences Co.,Ltd Company Detail

Table 103. Shanghai Junshi Biosciences Co.,Ltd Business Overview

Table 104. Shanghai Junshi Biosciences Co.,Ltd Melanoma Drugs Product

Table 105. Shanghai Junshi Biosciences Co.,Ltd Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 106. Shanghai Junshi Biosciences Co.,Ltd Recent Development

Table 107. Innovent Biologics Company Detail

Table 108. Innovent Biologics Business Overview

Table 109. Innovent Biologics Melanoma Drugs Product

Table 110. Innovent Biologics Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 111. Innovent Biologics Recent Development

Table 112. Jiangsu Hengrui Medicine Co.,Ltd. Company Detail

Table 113. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview

Table 114. Jiangsu Hengrui Medicine Co.,Ltd. Melanoma Drugs Product

Table 115. Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 116. Jiangsu Hengrui Medicine Co.,Ltd. Recent Development

Table 117. BeiGene, Ltd. Company Detail

Table 118. BeiGene, Ltd. Business Overview

Table 119. BeiGene, Ltd. Melanoma Drugs Product

Table 120. BeiGene, Ltd. Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 121. BeiGene, Ltd. Recent Development

Table 122. Grand Pharmaceutical (China) Co., Ltd Company Detail

Table 123. Grand Pharmaceutical (China) Co., Ltd Business Overview

Table 124. Grand Pharmaceutical (China) Co., Ltd Melanoma Drugs Product

Table 125. Grand Pharmaceutical (China) Co., Ltd Revenue in Melanoma Drugs Business (2019-2024) & (US$ Million)

Table 126. Grand Pharmaceutical (China) Co., Ltd Recent Development

Table 127. Research Programs/Design for This Report

Table 128. Key Data Information from Secondary Sources

Table 129. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Melanoma Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Melanoma Drugs Market Share by Type: 2023 VS 2030

Figure 3. Chemotherapy Features

Figure 4. Immunotherapy Features

Figure 5. Targeted Therapy Features

Figure 6. Global Melanoma Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Melanoma Drugs Market Share by Application: 2023 VS 2030

Figure 8. Hospitals Case Studies

Figure 9. Clinics Case Studies

Figure 10. Others Case Studies

Figure 11. Melanoma Drugs Report Years Considered

Figure 12. Global Melanoma Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Melanoma Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Melanoma Drugs Market Share by Region: 2023 VS 2030

Figure 15. Global Melanoma Drugs Market Share by Players in 2023

Figure 16. Global Top Melanoma Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Melanoma Drugs as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Melanoma Drugs Revenue in 2023

Figure 18. North America Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Melanoma Drugs Market Share by Country (2019-2030)

Figure 20. United States Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Melanoma Drugs Market Share by Country (2019-2030)

Figure 24. Germany Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Melanoma Drugs Market Share by Region (2019-2030)

Figure 32. China Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Melanoma Drugs Market Share by Country (2019-2030)

Figure 40. Mexico Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Melanoma Drugs Market Share by Country (2019-2030)

Figure 44. Turkey Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Melanoma Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Amgen Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 48. Roche Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 49. Genentech Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 50. Janssen Biotech Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 51. Novartis Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 52. Pfizer Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 53. Sanofi Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 54. Takeda Pharma Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 55. Teva Pharma Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 56. Merck Group Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 57. Shanghai Junshi Biosciences Co.,Ltd Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 58. Innovent Biologics Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 59. Jiangsu Hengrui Medicine Co.,Ltd. Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 60. BeiGene, Ltd. Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 61. Grand Pharmaceutical (China) Co., Ltd Revenue Growth Rate in Melanoma Drugs Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions